MSTR vs. NVO
MSTR (Strategy Inc) and NVO (Novo Nordisk A/S) are both stocks. MSTR operates in Software - Application (Technology), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, MSTR returned 21.08%/yr vs 6.20%/yr for NVO. At a 0.18 correlation, their price movements are largely independent.
Performance
MSTR vs. NVO - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with MSTR having a -16.29% return and NVO slightly lower at -16.56%. Over the past 10 years, MSTR has outperformed NVO with an annualized return of 21.08%, while NVO has yielded a comparatively lower 6.20% annualized return.
MSTR
- 1D
- 5.61%
- 1M
- -32.19%
- YTD
- -16.29%
- 6M
- -30.75%
- 1Y
- -66.03%
- 3Y*
- 65.16%
- 5Y*
- 19.92%
- 10Y*
- 21.08%
NVO
- 1D
- -4.52%
- 1M
- -10.96%
- YTD
- -16.56%
- 6M
- -9.23%
- 1Y
- -42.47%
- 3Y*
- -17.53%
- 5Y*
- 1.78%
- 10Y*
- 6.20%
MSTR vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MSTR Strategy Inc | -16.29% | -47.53% | 358.54% | 346.15% | -74.00% | 40.13% | 172.42% | 11.65% | -2.70% | -33.49% |
NVO Novo Nordisk A/S | -16.56% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between MSTR and NVO is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 1998 | 0.18 |
Fundamentals
MSTR:
$42.47B
NVO:
$182.49B
MSTR:
-$40.19
NVO:
$27.42
MSTR:
79.74
NVO:
0.56
MSTR:
1.16
NVO:
0.90
MSTR:
$490.47M
NVO:
$327.80B
MSTR:
$334.08M
NVO:
$268.30B
MSTR:
$466.93M
NVO:
$181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MSTR vs. NVO — Risk / Return Rank
MSTR
NVO
MSTR vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Strategy Inc (MSTR) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MSTR | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.12 | ||
| Sortino ratioReturn per unit of downside risk | -0.65 | ||
| Omega ratioGain probability vs. loss probability | 0.82 | 0.86 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | -0.86 | -0.77 | -0.09 |
| Martin ratioReturn relative to average drawdown | -1.27 | -1.14 | -0.12 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MSTR | NVO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.94 | -0.82 | -0.12 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.22 | 0.05 | +0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | 0.19 | +0.10 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | 0.47 | -0.35 |
Drawdowns
MSTR vs. NVO - Drawdown Comparison
The maximum MSTR drawdown since its inception was -99.86%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for MSTR and NVO.
Loading charts...
Drawdown Indicators
| MSTR | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.86% | -74.70% | -25.16% |
Max Drawdown (1Y)Largest decline over 1 year | -76.53% | -55.03% | -21.50% |
Max Drawdown (3Y)Largest decline over 3 years | -77.42% | -74.70% | -2.72% |
Max Drawdown (5Y)Largest decline over 5 years | -84.11% | -74.70% | -9.41% |
Max Drawdown (10Y)Largest decline over 10 years | -89.27% | -74.70% | -14.57% |
Current DrawdownCurrent decline from peak | -73.15% | -70.19% | -2.96% |
Average DrawdownAverage peak-to-trough decline | -86.47% | -17.77% | -68.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 52.19% | 37.21% | +14.98% |
Volatility
MSTR vs. NVO - Volatility Comparison
Strategy Inc (MSTR) has a higher volatility of 21.43% compared to Novo Nordisk A/S (NVO) at 9.75%. This indicates that MSTR's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MSTR | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.43% | 9.75% | +11.68% |
Volatility (6M)Calculated over the trailing 6-month period | 56.80% | 38.30% | +18.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 70.82% | 52.08% | +18.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 90.87% | 38.31% | +52.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 73.77% | 32.56% | +41.21% |
Dividends
MSTR vs. NVO - Dividend Comparison
MSTR has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.39%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MSTR Strategy Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 4.39% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
MSTR vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Strategy Inc and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MSTR and NVO have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MSTR has higher volatility (21.43%) compared to NVO (9.75%). In terms of maximum drawdown, MSTR dropped -99.86% vs NVO's -74.70%.
NVO currently has the higher Sharpe Ratio (-0.82 vs -0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MSTR and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer